We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over CAR-OLT

Schat cardiovasculaire complicatie risico na levertransplantatie.

The CAR-OLT score enables healthcare providers, caregivers and patients to estimate 1-year risk for cardiovascular complications after liver transplantation, defined as cardiovascular death or hospitalization due to myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism or stroke. Risk estimates from the CAR-OLT score are derived from a large cardiovascular risk in liver transplant cohort study published in 2017 in Hepatology ​​(VanWagner et. al. A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation:The CAR-OLT Score). The CAR-OLT score is intended for use in those age 18-75 years with liver disease who are undergoing evaluation for liver transplantation.

The information required to estimate 1-year post-liver transplant cardiovascular complication risk includes liver transplant candidate age, sex, race, employment status, highest education achieved, hepatocellular carcinoma status, diabetes status, heart failure status, atrial fibrillation status, pulmonary or systemic hypertension status and ventilator status.

Wat is er nieuw in de nieuwste versie 0.0.6

Last updated on Sep 24, 2018

Updated branding

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van CAR-OLT 0.0.6

Geüpload door

Awatif Om Fuaad

Android vereist

Android 4.1+

Meer Info

CAR-OLT Screenshots

Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.